Zobrazeno 1 - 10
of 226
pro vyhledávání: '"sC5b-9"'
Autor:
Eun Bin Cho, Ju-Hong Min, Patrick Waters, Miyoung Jeon, Eun-Seon Ju, Ho Jin Kim, Su-Hyun Kim, Ha Young Shin, Sa-Yoon Kang, Young-Min Lim, Sun-Young Oh, Hye Lim Lee, Eunhee Sohn, Sang-Soo Lee, Jeeyoung Oh, Sunyoung Kim, So-Young Huh, Joong-Yang Cho, Jin Myoung Seok, Byung-Jo Kim, Byoung Joon Kim
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundMyelin oligodendrocyte glycoprotein antibody (MOG) immunoglobulin G (IgG)-associated disease (MOGAD) has clinical and pathophysiological features that are similar to but distinct from those of aquaporin-4 antibody (AQP4-IgG)-positive neurom
Externí odkaz:
https://doaj.org/article/bdb26411794549f2a09113964aad16be
Autor:
Ryoko Yamane, Yoshinari Yasuda, Aki Oshima, Yasuhiro Suzuki, Hiroshi Kojima, Hangsoo Kim, Sosuke Fukui, Shoichi Maruyama, Yasuhiko Ito, Masashi Mizuno
Publikováno v:
BMC Nephrology, Vol 24, Iss 1, Pp 1-10 (2023)
Abstract Background During the last few decades, pathogenic mechanisms associated with uncontrolled activation of the complement (C) system and development of anti-C agents have been closely investigated in the field of nephrology. The usefulness of
Externí odkaz:
https://doaj.org/article/27932b229815480f98f2ba7e50af9bbe
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Katsuichi Miyamoto, Mai Minamino, Motoi Kuwahara, Hiroshi Tsujimoto, Katsuki Ohtani, Nobutaka Wakamiya, Kei-ichi Katayama, Norimitsu Inoue, Hidefumi Ito
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Complement is involved in the pathogenesis of neuroimmune disease, but the detailed pathological roles of the complement pathway remain incompletely understood. Recently, eculizumab, a humanized anti-C5 monoclonal antibody, has been clinically applie
Externí odkaz:
https://doaj.org/article/caa4c76c43d4434c9d90fec41513356f
Autor:
Noriaki Kawano, Tomohiro Abe, Naoko Ikeda, Yuri Nagahiro, Sayaka Kawano, Taro Tochigi, Takashi Nakaike, Kiyoshi Yamashita, Keisuke Kubo, Atsushi Yamanaka, Sohshi Terasaka, Kousuke Marutsuka, Koichi Mashiba, Ikuo Kikuchi, Kazuya Shimoda, Masanori Matsumoto, Hidenobu Ochiai
Publikováno v:
Renal Replacement Therapy, Vol 8, Iss 1, Pp 1-15 (2022)
Abstract Background Although atypical hemolytic uremic syndrome (aHUS) is a life-threatening clinical entity that was characterized by thrombotic microangiopathy (TMA) with the activation of the complement system and the efficient treatment of eculiz
Externí odkaz:
https://doaj.org/article/1f30f8df95f742b0ac12a036619d7910
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
Transplant-associated thrombotic microangiopathy (TA-TMA) is an increasingly recognized complication of allogeneic and autologous hematopoietic cellular therapy (HCT), associated with significant morbidity and mortality. Although the central drivers
Externí odkaz:
https://doaj.org/article/69440a08d54b4ad399b9de688d7154a8
Autor:
Marta Budkowska, Ewa Ostrycharz, Natalia Maria Serwin, Łukasz Nazarewski, Elżbieta Cecerska-Heryć, Marta Poręcka, Paweł Rykowski, Radosław Pietrzak, Krzysztof Zieniewicz, Aldona Siennicka, Beata Hukowska-Szematowicz, Barbara Dołęgowska
Publikováno v:
Biomedicines, Vol 11, Iss 7, p 2070 (2023)
The liver has a huge impact on the functioning of our body and the preservation of homeostasis. It is exposed to many serious diseases, which may lead to the chronic failure of this organ, which is becoming a global health problem today. Currently, t
Externí odkaz:
https://doaj.org/article/859ae9208a434cfeac45529226649ddd
Autor:
Cathryn M. Kolka, Julie Webster, Ailin Lepletier, Clay Winterford, Ian Brown, Renee S. Richards, Wioleta M. Zelek, Yilang Cao, Ramlah Khamis, Karthik B. Shanmugasundaram, Alain Wuethrich, Matt Trau, Sandra Brosda, Andrew Barbour, Alok K. Shah, Guy D. Eslick, Nicholas J. Clemons, B. Paul Morgan, Michelle M. Hill
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The early complement components have emerged as mediators of pro-oncogenic inflammation, classically inferred to cause terminal complement activation, but there are limited data on the activity of terminal complement in cancer. We previously reported
Externí odkaz:
https://doaj.org/article/7a5670f9f3814e8daeeeb4ffc389c13c
Autor:
Myriam Khalili, Arnaud Bonnefoy, Dominique S. Genest, Jérémy Quadri, Jean-Philippe Rioux, Stéphan Troyanov
Publikováno v:
Kidney International Reports, Vol 5, Iss 10, Pp 1690-1699 (2020)
Introduction: Complement activation, inflammation, and fibrosis play central roles in the mechanisms of injury in autoimmune glomerulonephritis (GN) but they are seldom assessed in epidemiologic studies. The measurement of urinary biomarkers of these
Externí odkaz:
https://doaj.org/article/a5785a96e211411591af7d78d08dcba9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.